D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
Vestis
VSTS
$1.91B
| $582K | ﹤0.01% |
74,070
-12,321
| -14% | -$90K |
2024 Q4
5 quarters
|
|
3677
PUT
SolarEdge
SEDG
$1.89B
| $582K | ﹤0.01% |
11,400
-233,600
| -95% | -$8.79M |
2019 Q4
25 quarters
|
|
3678
PUT
Warrior Met Coal
HCC
$4.7B
| $578K | ﹤0.01% |
6,200
-19,700
| -76% | -$1.77M |
2025 Q2
3 quarters
|
|
3679
Ameris Bancorp
ABCB
$5.33B
| $577K | ﹤0.01% |
7,392
+3,358
| +83% | +$267K |
2025 Q1
4 quarters
|
|
3680
PUT
Howard Hughes
HHH
$4.18B
| $576K | ﹤0.01% |
+9,100
| New | +$682K |
2026 Q1
0 quarters
|
|
3681
PUT
Fabrinet
FN
$13.5B
| $574K | ﹤0.01% |
+1,100
| New | +$559K |
2026 Q1
0 quarters
|
|
3682
Stepan Co
SCL
$1.4B
| $574K | ﹤0.01% |
11,478
-69,652
| -86% | -$3.73M |
2024 Q4
5 quarters
|
|
3683
Neuropace
NPCE
$439M
| $574K | ﹤0.01% |
+43,625
| New | +$654K |
2026 Q1
0 quarters
|
|
3684
PUT
Inspire Medical Systems
INSP
$2B
| $573K | ﹤0.01% |
+11,100
| New | +$777K |
2026 Q1
0 quarters
|
|
3685
CALL
H&R Block
HRB
$5.96B
| $571K | ﹤0.01% |
18,000
-27,400
| -60% | -$955K |
2025 Q4
1 quarter
|
|
3686
Braemar Hotels & Resorts
BHR
$98.2M
| $568K | ﹤0.01% |
240,497
-45,309
| -16% | -$126K |
2025 Q2
3 quarters
|
|
3687
Huya Inc
HUYA
$528M
| $565K | ﹤0.01% |
171,217
+75,615
| +79% | +$279K |
2025 Q3
2 quarters
|
|
3688
CALL
Arrowhead Research
ARWR
$8.15B
| $564K | ﹤0.01% |
9,000
-9,000
| -50% | -$570K |
2025 Q4
1 quarter
|
|
3689
PUT
Motorola Solutions
MSI
$75.8B
| $564K | ﹤0.01% |
1,300
| – | – |
2025 Q4
1 quarter
|
|
3690
Oric Pharmaceuticals
ORIC
$1.3B
| $562K | ﹤0.01% |
44,390
+28,368
| +177% | +$322K |
2025 Q4
1 quarter
|
|
3691
Alico
ALCO
$282M
| $561K | ﹤0.01% |
13,604
-653
| -5% | -$25.9K |
2025 Q2
3 quarters
|
|
3692
CALL
Dave & Buster's
PLAY
$270M
| $560K | ﹤0.01% |
51,700
-60,700
| -54% | -$970K |
2024 Q3
6 quarters
|
|
3693
DELISTED
Clearwater Analytics
CWAN
| $559K | ﹤0.01% |
23,643
-71,474
| -75% | -$1.69M |
2025 Q4
1 quarter
|
|
3694
PUT
Global Payments
GPN
$22.2B
| $559K | ﹤0.01% |
8,300
-12,900
| -61% | -$951K |
2025 Q1
4 quarters
|
|
3695
Lionsgate Studios
LION
$3.27B
| $557K | ﹤0.01% |
58,126
-112,736
| -66% | -$1.04M |
2025 Q2
3 quarters
|
|
3696
F5
FFIV
$25.6B
| $557K | ﹤0.01% |
1,926
-19,606
| -91% | -$5.44M |
2013 Q2
51 quarters
|
|
3697
KRONOS Worldwide
KRO
$845M
| $556K | ﹤0.01% |
84,656
-44,013
| -34% | -$250K |
2025 Q3
2 quarters
|
|
3698
Sportradar
SRAD
$3.59B
| $556K | ﹤0.01% |
33,195
+4,072
| +14% | +$75.7K |
2023 Q2
11 quarters
|
|
3699
e.l.f. Beauty
ELF
$6.73B
| $555K | ﹤0.01% |
9,163
-34,429
| -79% | -$2.8M |
2025 Q4
1 quarter
|
|
3700
John Wiley & Sons Class A
WLY
$2.67B
| $555K | ﹤0.01% |
14,555
-132,841
| -90% | -$4.31M |
2023 Q1
12 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.